Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Epistem
Epistem
Activities:
Research & Development
X
LinkedIn
Trending Articles
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Adare expands global handling & packaging capabilities
The company will have enhanced compaction, milling, bin blending and tablet compression capabilities in Philadelphia, Ohio and Milan
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Making the most of each cell: single-use perfusion in biopharma processing
GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing,...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Pharmaceutical
David Budd to join Epistem as Chief Executive
He will start his new role by the middle of April
Research & Development
Epistem opens US laboratory in Baltimore
Currently offers histology and immunohistochemistry (IHC) services
Research & Development
UK-Norwegian team to develop living skin equivalent testing model
For testing inflammatory responses
Research & Development
Epistem announces three-year collaboration with GSK
Will apply RND-Amp technology to fibrosis research
Research & Development
Epistem signs three-year research deal with sanofi-aventis
Will provide discovery through to clinical biomarker support to sanofi-aventis oncology programmes
Research & Development
Epistem awarded US$3.5m in NIH biodefence contract
Consortium is developing drugs to treat radiation damage to the gastrointestinal tract
Manufacturing
Veritas becomes exclusive distributor in Japan for Epistem
Will enable Epistem to extend its research services in the region
Subscribe now